Their technology uses novel sample preparation methods, machine learning algorithms, and a world-class database of WGS and drug efficacy profiles to deliver a complete diagnosis, including both the species and antibiotic resistance profile, in hours vs. days, enabling physicians to use a targeted treatment on day zero of hospital admission and resulting in better patient outcomes and cost savings. They are targeting bloodstream infections and sepsis for their first application, with the aim of transforming the way infectious disease diagnostics are performed.